Âé¶ą´«Ă˝É«ÇéƬ

Journal News

JBC: What bacteria can teach us about combating atrazine contamination

Sasha Mushegian
Oct. 1, 2018

Atrazine, a controversial herbicide introduced to agriculture in the 1950s, has been banned in the European Union but is used widely in the United States and Australia. In the decades that atrazine has been accumulating in agricultural fields, some bacteria in those soils have evolved the ability to take advantage of this nitrogen-rich compound, metabolizing it and using it to grow.

A newly described protein complex carries out a step in bacterial breakdown of the herbicide atrazine. The two AtzE molecules are in blue and green, and the two AtzG molecules are in yellow and magenta.Courtesy of Colin Scott/CSIRO

Researchers at the Commonwealth Scientific and Industrial Research Organization of Australia, or , are interested in harnessing bacterial ability to degrade atrazine in order to remediate atrazine-polluted environments. In a published in the Journal of Biological Chemistry, a team from CSIRO and the Australian National University describe previously unknown proteins involved in atrazine degradation — and the insights these can give us into how bacteria evolve new abilities in response to chemicals synthesized by humans.

“Bacteria are really good at evolving to be able to exploit new nutrient sources, and they do this by adapting existing cellular machinery for novel functions,” said , leader of the Biocatalysis and Synthetic Biology Team at CSIRO, who oversaw the work.

Turning atrazine into a usable nitrogen source is a multistep process for bacteria, involving multiple enzymes. Before widespread atrazine pollution, each of these enzymes served different functions in bacterial cells. In atrazine-degrading bacteria, the genes encoding these enzymes are grouped on a section of DNA called a plasmid, which can be passed easily between bacteria, giving them a ready-made adaptation.

“Within 10 years from its original discovery (in the 1990s), genes from this pathway were found (in bacteria) on pretty much every continent except Antarctica,” Scott said.

In other words, as atrazine use spread across the globe, so did the bacterial ability to metabolize it.

Whereas the enzymes involved in several of these steps have been described thoroughly, the structure of one of them, called AztE, was still unknown. AztE is crucial for converting cyanuric acid — an intermediate step in the atrazine degradation process — into ammonia.

, a Ph.D. student in Scott’s lab, led the effort to purify this protein. When the team examined the protein, it found something surprising: another very small protein, the existence of which had not been predicted from the bacterium’s genome sequence, forming a complex with AztE. This new protein, which the team named AztG, seemed to be necessary to stabilize the structure of AztE.

Together, the structure of AztE and AztG resembled a different bacterial protein complex — the transamidasome, which helps make bacterial transfer RNA. Thus, it appeared that proteins involved in the basic functions of the bacterial cell were retooled for the new atrazine pathway.

The transamidasome “is absolutely essential for bacteria in the way that they make their tRNAs,” Scott said. “It was somewhat surprising that our protein, which is involved in pesticide catabolism, was (similar) to this protein complex that’s used in central metabolism.”

The promise of synthetic biology is that humans can combine genes encoding different functions in an organism in creative ways. However, although it’s relatively simple to insert genes into new contexts, a newly constructed pathway is not guaranteed to work as intended. It’s therefore instructive to examine pathways like the atrazine degradation pathway, in which bacteria have successfully repurposed a series of unrelated genes to do something new.

“This (pathway) has come from other places and been cobbled together, but there must be some underlying rules and constraints about how to do that,” Scott said. “We don’t know at the moment what the design rules are for complex pathways in terms of their genetic architecture. What we want to do is to use the cyanuric acid pathway as a model to understand some of those design principles.”

Atrazine-degrading bacteria convert atrazine into nitrogenous compounds that plants potentially could use as fertilizer, but this poses its own problems: Nitrogen runoff into water causes algal blooms and animal die-offs. Thus, a key problem that CSIRO researchers are trying to solve is how to contain the reaction so that it occurs only where and how humans need it. One approach is to use targeted application of enzymes purified from these bacteria rather than the bacteria themselves.

“As a technology, we’ve gone out to the field and proven that (the enzymes) can work,” Scott said. “The next step is working with industry to try to implement some of these solutions.”

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Sasha Mushegian

Sasha Mushegian is a postdoctoral fellow at Georgetown University. Follow her on Twitter.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.

Receptor antagonist reduces age-related bone loss in mice
Journal News

Receptor antagonist reduces age-related bone loss in mice

Aug. 6, 2025

Receptor antagonist reduces bone loss and promotes osteoblast activity in aging mice, highlighting its potential to treat osteoporosis. Read more about this recent JBC paper.

Engineered fusion protein targets kiwifruit pathogen
Journal News

Engineered fusion protein targets kiwifruit pathogen

Aug. 6, 2025

Synthetic protein selectively kills kiwifruit pathogen, offering a promising biocontrol strategy for agriculture. Read more about this recent JBC paper.